AusCann says it is transitioning to a pharmaceutical production and sales business.

AusCann appoints CEO

Medical cannabis company AusCann Group Holdings has appointed international pharmaceutical executive Ido Kanyon as its new chief executive, nearly five months after it was announced that Elaine Darby would resign from the role.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Top 10 Shareholders

Source: Morningstar

Total Shareholder Return as at 30/04/19

1 year TSR5 year TSR
101st4DS Memory38%-5%
726thUltima United-65%-14%
801stAusCann Group Holdings-79%58%
729 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$11k Bought
$47k Bought
$15k Issued
Total value as at the date of the transaction
Source: Morningstar


176th↑AusCann Group Holdings$54k
182nd↑4DS Memory$6k
183rd↑Ultima United$4k
186th↓Mission NewEnergy$5
199 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer